Results 221 to 230 of about 79,283 (266)

INHIBITORS OF MEK KINASE

2023
KANOUNI TOUFIKE, KANIA ROBERT S, COX JASON M   +2 more
openaire   +4 more sources

A Mathematical Model for the Treatment of Melanoma with the BRAF/MEK Inhibitor and Anti-PD-1

Applied Sciences (Switzerland), 2022
Ophir Nave, Nave Ophir
exaly  

Clinical Development of BRAF plus MEK Inhibitor Combinations

Trends in Cancer, 2020
John M Kirkwood, Vivek Subbiah, Christina Baik   +2 more
exaly  

MEK INHIBITORS AND USES THEREOF

2023
CASTRO ALFREDO C, BURKE MICHAEL J, WYNN THOMAS A, RUPPEL SABINE K, SANTILLANA SOTO SERGIO L, HAINES ERIC, XU LAN, ZAVIDIJ OKSANA   +7 more
openaire   +2 more sources

ONC201 and an MEK Inhibitor Trametinib Synergistically Inhibit the Growth of Triple-Negative Breast Cancer Cells

Biomedicines, 2021
, Jangsoon Lee, Christine B Peterson
exaly  

A phase IB trial of the oral MEK inhibitor trametinib (GSK1120212) in combination with everolimus in patients with advanced solid tumors

Annals of Oncology, 2015
J R Infante, J C Bendell, D Rasco
exaly  

The HSP90 inhibitor, NVP-AUY922, sensitizes KRAS-mutant non-small cell lung cancer with intrinsic resistance to MEK inhibitor, trametinib

Cancer Letters, 2016
Dae Ho Lee, Sang-We Kim, Kang-Seo Park
exaly  

Combined Therapy with Anti-PD1 and BRAF and/or MEK Inhibitor for Advanced Melanoma: A Multicenter Cohort Study

Cancers, 2020
Olivier Dereure, Marie Boileau, François Aubin   +2 more
exaly  

Management of BRAF and MEK inhibitor toxicities in patients with metastatic melanoma

Therapeutic Advances in Medical Oncology, 2015
Sarah Welsh, Pippa Corrie
exaly  

INHIBITORS OF MEK

2008
KOH YUNG-HYO, HONG ZHI, VERNIER JEAN-MICHEL, MADERNA ANDREAS   +3 more
openaire   +4 more sources